QUÉBEC CITY, June 19, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the "Company") today announces that the Company has
learned that two putative class action lawsuits have been filed against
it alleging failures to disclose certain information under U.S. federal
securities laws. The Company is in the process of reviewing the
allegations, believes they are without merit and stands behind its
continuous public disclosure record. Aeterna Zentaris believes that
there is absolutely no basis for the lawsuits, and the Company intends
to defend itself vigorously.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company's pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.